chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Body ache; Fever; Headache; I was stuck in my right arm; I am really worried about symptoms; A report was received from a healthcare professional concerning a 30-year old, female patient who experienced fever, headache, body ache, I was stuck in my right arm and I am really worried about my symptoms.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 23 Dec 2020, approximately 1 day and 10 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (BATCH # 037K20A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 24 Dec 2020 at about 10 am, the patient began to feel a fever, headache, body ache, stuck in right arm and really worried about her symptoms. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of the events, fever, headache, body ache, I was stuck in my right arm and I am really worried about my were unknown.   The reporter did not provide an assessment for the events, fever, headache, body ache, I was stuck in my right arm and I am really worried about my symptoms.; Reporter's Comments: This case concerns a 30-year-old female who experienced NS unexpected events of musculoskeletal stiffness, pain, anxiety and NS expected events of fever, headache.  The events occurred 2 days after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Chills, body ache, headache, excessive thirst, headache, lightheaded/dizzy, fever up to 102.5 F
Had the COVID shot and two days later he can't use the arm. Right shoulder hurts very badly. Also the shoulder joint hurts. Top of shoulder can't use the arm. Painful, very sore.
pt recvd 3 doses of Engerix-B & was a nonresponder; given a booster dose of Engerix-B 13JUL92;
Pain & redness at injection site. Mild wheezing. Temp 99 degrees.
This spontaneous report as received from a nurse refers to multiple patients of unknown age and gender. No concurrent conditions, medical history, allergy/drug reactions and concomitant medications were reported. On unspecified dates, the patients were vaccinated with improperly stored ROTATEQ lot#L033693 with expiry date: 31-MAY-2017, lot#M014544 with expiry date:27-NOV-2017, lot#M025568 with expiry date: 07-NOV-2017, lot#L029617 with expiry date: 19-MAY-2017 and lot#M007311 with expiry date: 30-NOV-2017 (dosing details, anatomical location, were unknown) via oral route for prophylaxis. All doses of ROTATEQ with lot# L029617 and lot# L033693 were administered prior to expiration dates. No adverse effects were reported. There were no product quality complaints (PQC) involved. This is one of the several reports from the same reporter. Sender's Comments: US-009507513-1708USA011339.
severe dizziness; This is a spontaneous report from a contactable consumer (patient).  A 67-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number: EL3248, expiry date unknown), via an unspecified route of administration on 29Jan2021 at 10:30 at a single dose on the left arm for COVID-19 immunization.  Medical history included ongoing diabetes from an unspecified date for about 3 years and ongoing Hashimoto's thyroiditis from an unspecified date for about 15 years. There were no concomitant medications. The patient did not other vaccinations within 4 weeks prior to the COVID vaccine. The patient reported that in the morning of 01Feb2021, 2 hours before calling, she started having severe dizziness to the point she was laying down, because she has to lay still. She can't go out of the room. She called her doctor and her doctor called in meclizine 25mg for her which she has not started yet. The patient was asking if this was safe to take and if it is counterintuitive to the shot. She has not picked it up yet. Her doctor didn't know anything about the vaccine other than she knows that the patient took the vaccine. The outcome of the event was not recovered.
On the evening of 10/8/21, I noticed a tender, mobile lump posterior upper thigh, 1-2 cm diameter.  The nurse practitioner examined it on 10/13/21 and suspected it is a benign reactive lymph node.  Did not think it was related to malignancy.
This 2 month old female received her first set of immunizations (DTaP-HepB-IPV, HIB PRP-T, PCV13, and oral RSV0 on 5/16/2012 at 0943 AM. Mom advised her daughter cried but was easily consoled and dozed off. Mom advised approximately 30-45 minutes after vaccinations she had her daughter in a chest sling while grocery shopping when she noted her arms and legs were twitching and jerking. Mom remembers rocking her daughter for approximately 1 minute with resolution of symptoms. She denied any change in skin color, fever, vomiting, spitting/drooling, apnea, head or body rocking/arching, or abnormal eye movements. She last feed her daughter Similac about 2-3 hours before this event. Child settled and slept normally and did not rouse when placed back in car seat. Child easily awoke about 2-3 hours after vaccinations, was a little fussy and was not eating as much (1 feeding only). Mom did notice mild immunization site irritation (redness), but did not notice any fever as she was giving Tylenol prophylactically. Mom has not noticed any recurrence of above jerking-twitching or any abnormalities in her daughter's behavior or sleeping patterns prior to or following this event. Child currently (6/5/2012) is acting age appropriately by moving all extremities, eats well, smiles and is starting to laugh, grasps objects placed in hands, sucks pacifier, watches mom and is responsive with siblings. Mom questions DTaP as possible cause of reaction after reviewing VIS form side effects. Childs physician, requested consults with VHC for recommendations on future vaccines.
3OCT92 t103, lethargic; 4OCT92 t104-104.2, vomited, grand mal seizures x's 2, @ 930 & 1045PM; 5OCT92 t103-104 APAP given, vomiting, nausea & lethargic-also ER visit-t105.8;
swelling, redness, warmth of the arm; swelling, redness, warmth of the arm; swelling, redness, warmth of the arm; This is a spontaneous report from a contactable physician. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown) via intramuscular route of administration in the left arm on 18May2021 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, hyperlipidemia, osteopenia and chronic kidney disease (CKD). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient had received any other vaccines within four weeks prior to the vaccination. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), hydrochlorothiazide (HCTZ) (MANUFACTURER UNKNOWN), buspirone (MANUFACTURER UNKNOWN) and atenolol (MANUFACTURER UNKNOWN) all for an unknown indication on an unknown date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on 27Apr2021 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. On 18May2021, the patient experienced swelling, redness and warmth of the arm. It was reported that the swelling and warmth had resolved, but there was still extensive erythema involving perhaps 25% of the skin surface of the upper arm. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of swelling, redness and warmth of the arm and included treatment with ibuprofen (MANUFACTURER UNKNOWN) and reassurance. The clinical outcome of the events swelling and warmth of the arm was recovered on an unknown date in May2021; redness was recovering at the time of this report.  Follow-up attempts are completed. No further information is expected. Batch/lot number not available for BNT162B2
Severe chest pain, shortness of breath, rapped heart beat, fluttering heart beat,  burning sensation in chest. Strated a few hours after vaccine and continues 1 week later. Have not seen a Dr., no medical insurance.
Had no immediate issues with the vaccine. He had returned from the hospital on 12/21 and had some concerns about his weight which were shared with his physician on 1/4/21. On 1/5/21 had a visit with his cardiologist for a pacemaker check. On 1/8/21 staff were called to his room, he was on the floor, bluish skin color. No vital signs found, no heart rhythm heard at 2200.
shingles; This spontaneous report was received from a consumer referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On an unknown date, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) (dose, route of administration, lot number and expiration date not reported) for prophylaxis.         On an unknown date, the patient experienced shingles (herpes zoster).      The outcome of herpes zoster and its causal relationship with the vaccine was not reported.
I had a headache, sinus pressure, congestion in my lungs, dry mouth, mouth sores, aches, diarrhea, but no fever. I took a COVID-19 test on 03/12/2023 which came back positive almost immediately. I called my doctor days later and was prescribed Paxlovid. I picked up the prescription but decided not to take as I began feeling better around day 4 or so after testing positive. Before picking up Paxlovid, I was taking Mucinex, Tylenol, and Nyquil to aid my recovery which is why I opted out taking the Paxlovid prescription. As of now, I'm making a recovery and treating my symptoms with Mucinex; I still haven't fully regained my voice, but still getting better slowly.
Patient reported mild chills, headache, and temp of 101 overnight. Patient went to ER for evaluation.
Had flu shot at approximately 3:30 pm on 9/12/20 and broke out in hives at approximately 6:30 pm on 9/12/20
At time of the shot, just a sore arm for about a day.  Then fine for a week.  One week later the injection site started to itch.  By the 8th day, there was a red itchy rash at injection site.
blurred vision; bodyache; increased heart rate; nausea; clamminess; dizziness/ lightheadedness; headache; Initial information regarding this unsolicited valid non-serious case received from a pharmacist and transmitted to Sanofi on 04-Nov-2019.  This case involves a 27 years old female patient who experienced blurred vision (PT: vision blurred), bodyache (PT: pain), increased heartrate (PT: heart rate increased), nausea (PT: Nausea), clamminess (PT: cold sweat), dizziness (PT: dizziness), headache (PT: headache) and lightheadedness (PT: Dizziness), while she received vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE].  Relevant medical history and concomitant medication were unknown.  No other vaccine was given.  On 02-Oct-2019, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (0.5 ml Vial) (lot: UJ223AB expiry date: 30-Jun-2020) via intramuscular route in the right arm.  On 02-Oct-2019, the patient developed a non-serious blurred vision (PT: vision blurred), bodyache (PT: pain), increased heartrate (PT: heart rate increased), nausea (PT: Nausea), clamminess (PT: cold sweat), dizziness (PT: dizziness), headache (PT: headache) and lightheadedness (PT: Dizziness), 30 minutes following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED.  Action taken was not applicable.  Corrective treatment was unknown for all events.  At the time of reporting, outcome was unknown for all events.
3 days after IM injection of PNEUMOVAX, pt called and came into to clinic due to complaints that her injection site was warm to touch and had a 3.5 x 3 inch redness to the injection site. Edges of inflammation marked and patient was provided prescription for Keflex 500mg po BID x 7 days which she will start if the swelling does not diminish or worsens. Patient was already receiving ciprofloxacin for UTI.
This spontaneous report as received from a Medical Assistant concerning a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of VARIVAX (Merck) (dose and route not reported); (Lot #G007459; exp. date: 02-AUG-2013). No other co-suspect therapy was reported. Concomitant medications were not provided. Medical Assistant reported that an expired dose of VARVIAX (Merck) was administered to a patient on 20-AUG-2013. No adverse effects had been reported. Additional information has been requested.
Shivering for 3-4 hours, tiredness, muscle aches, sinus drainage
I received my shot 4/2.  When I woke up 4/3 I have a terrible headache which I still have.  Also ONLY the left side of my body hurts. Neck, down to fingers.  Ribs through lower left side of my back and pain that shoots down my left leg.
nonurticarial rash started in the evening - L chest. next day, spread to torso, both arms.
patient's mom yelled that she was having a reaction  a few minutes after the vaccination. Patient was very pale, looked unwell. said she was feeling dizzy and bad. had her put her head between her knees. said she hadn't eaten anything that day, gave her some orange juice. we had called ED as a precaution because mom had at first thought she might be having a seizure. Paramaedics came and evaluated her. She was feeling better about 20 minutes later so mom took her home.
Rash on sides started Thursday. Woke up Friday and rash is all over body itching red and hurts. Taken Benadryl, pepsid and hydrocortisone cream. Called tele doc they gave prednisone nothing is working getting worse
May 10 - I awoke unable to hear out of my right ear. It was sudden. No symptoms prior. I have been treated  -1st - with OTC allergy med - daytime kind and night time kind and she prescribe a nasal spray for 3 times a day. That was on Monday and on Thursday I called her back and she said to take an antibiotic - she called in a prescription. I was a little better but not significant. ENT - tested: Said I have Sudden Sensorineural Hearing Loss and that doctor treated me with Prednisone - I was on it for 60 days (45 days or so on high dose and 10 days or so on a low dose).  Some of my hearing has come back but not all of it  - so now I have a hearing aid. I'm also having memory problems - I am forgetting words; they don't come to me right. People's names - People that I work with - I can't think of their names; they are not close coworkers but I still work with them.  I might call something a name and know it's the wrong name but it's what comes out of my mouth. I can tell it's wrong and I'll correct. I get stuck on a syllable and repeat it several times - like a stutter. I did get parts of my hearing back after being on Prednisone and an anti-viral med which she gave me, too. My hearing - when I lost it - I have tinnitus that I've had for years - 30 years ago. But when I lost the hearing - I could hear the tinnitus really loudly and it is very bothersome. It's much louder than it is in my right ear. I could not hear anything external in that right ear. When it started getting better, the tinnitus is still there and it is still louder. That only improves with my earing aid. The hearing aid prevents the tinnitus from being so loud. It is constant - it doesn't stop. I'm also having some joint pain in hands, fingers and feet. This pain inhibits my daily activities at work and at home. I didn't notice this pain until June.  I was having spasms in them - like when you get a Charlie horse in them. The spasms are settling down but I still have pain in the joints of my hands and my feet. I'm off steroids now and I'm still hurting. I don't know if these are vaccine related symptoms.
Jynneos administered intramuscularly; Case reference number US-BN-2022-001695 is a spontaneous case report initially received on 27-Jul-2022 from a health care professional (reference number: USBAV22-0690) and concerns a *35-years-old male patient*.  The patient's medical history and concomitant medication details were not reported.  On *13-Jul-2022*, the patient was vaccinated with the first dose of Jynneos (Smallpox and Monkeypox Vaccine, Live, Nonreplicating, batch number: FDP00002), intramuscularly (IM), at a dose of 0.5 mL, at the *left deltoid* for pre-exposure prophylaxis (PrEP) (explicitly coded as Inappropriate route of vaccination'). As reported, the patient worked in a lab that handled monkeypox samples.   At the time of this report, it was known that the patient did not experience any adverse events due to Jynneos vaccination.  This case is linked with case no. US-BN-2022-001673, US-BN-2022-001687, US-BN-2022-001688, US-BN-2022-001689, US-BN-2022-001690, US-BN-2022-001691, US-BN-2022-001692, US-BN-2022-001693, US-BN-2022-001694, US-BN-2022-001696, US-BN-2022-001697, US-BN-2022-001698, US-BN-2022-001699, US-BN-2022-001700, US-BN-2022-001701, concerning the same reporter.  Non-significant case correction received from Bavarian Nordic on 29-Jul-2022 included an additional reference number.  All follow-up information is blended into the case narrative above, with the latest information presented between asterisks (*).  Follow-up information received from a healthcare professional via Bavarian Nordic on 09-Aug-2022 included patient details and additional information about the administrated dose of Jynneos.; Reporter's Comments: A 35-year-old male patient was vaccinated with the first dose of Jynneos, intramuscularly, at dose of 0.5 mL, at the left deltoid, for pre-exposure prophylaxis which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company. At this point, it was known that the patient did not experience any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not reported. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A 35-year-old male patient was vaccinated with the first dose of Jynneos, intramuscularly, at dose of 0.5 mL, at the left deltoid, for pre-exposure prophylaxis which is considered as inappropriate route of vaccination. Incorrect route of product administration is considered listed per company convention. At this point, it was known that the patient did not experience any adverse event due to Jynneos vaccination. The patient's medical history and concomitant medication details were not reported. Causality is assessed as not related to suspect product but to human factor. The case is non-serious.
Two days after vaccination the patient's left arm at the site of the injection became sore and after a month is still sore. There was no redness or lumps. The patient was advised to try warm compresses.
Muscle at the sight of the injections has deteriorated to a notable colapse at the injection sight. At times the arm is sore and weak.
This case was reported by a lawyer and described the occurrence of Hashimoto's thyroiditis in a 52 year old female pt who received Lyme disease vaccine recombinant OspA (Lymerix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the pt received Lymerix. At an unknown time after receiving Lymerix, the pt experienced Hashimoto's thyroiditis, fatigue, headache, depression, vertigo, and memory loss. Time to onset, treatment and outcome were not reported. Comment: Hashimoto's thyroiditis is considered medically serious by manufacturer (OMIC). Per follow up report received 03/21/2005:  Legal case, follow up unavailable.
Arm soreness at injection site - swollen, itchy and sore. That lasted for three days. I got some swelling in lymph node under the arm. I had all over body aches that I treated with ibuprofen and those lasted about 36 hours. On Wednesday, 3/31/2021, I got a sore throat and had really bad tonsillitis for about four days ( Wed- Sunday 4/4/2021). If I had a temp it wasn't significant. I didn't have spots in my throat - just a really bad sore throat. Around 4/5/2021, I started getting an ear infection later in that day. April 7, Ear infection got really, really, really bad. By 01:00 pm, my eardrum was starting to perforate. I had intense pain and fluid coming out of my ear. Called my doctor and he started me on antibiotics  and Hydrocodone and high dose ibuprofen and compress helped. By 6:00 pm, it was done perforating. It took about 4 weeks for it to heal.
bad cough - having chest pain from coughing, headache - migraine, nausea, fever. Pt got vaccine yesterday, last night had all these symptoms, getting better today.
PAXAES report with Pfizer BioNTech Vaccine administered(patient also took paxlovid for covid-19 treatment after received BNT162b2); Report with Pfizer BioNTech Vaccine administered(patient also took paxlovid for covid-19 treatment after received BNT162b2); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 17Mar2021 as dose 2, single (Lot number: EP7534), in right arm and on 15Oct2021 as dose 3 (booster), single (Lot number: EN6203) at the age of 47 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hashimotos" (unspecified if ongoing), notes: Other medical history: Hashimotos; "Known allergies: Gluten" (unspecified if ongoing), notes: Known allergies: Gluten, penicillin; "Known allergies: penicillin" (unspecified if ongoing), notes: Known allergies: Gluten, penicillin. Concomitant medication(s) received in 2weeks of vaccination which included: TIROSINT, start date: 01Dec2011; LEXAPRO, start date: 01Mar2022. The following information was reported: VACCINATION FAILURE (medically significant) with onset 05May2022, outcome "unknown", COVID-19 (medically significant) with onset 05May2022, outcome "recovering" and all described as "report with Pfizer BioNTech Vaccine administered(patient also took paxlovid for covid-19 treatment after received BNT162b2)". Therapeutic measures were not taken as a result of covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This is a spontaneous report from a contactable physician. This report was received via a Pfizer sales representative. A patient of unspecified age and gender received PREVNAR 13, (batch number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced bad diarrhea GI symptoms on an unspecified date. The outcome of the event was unknown. The information on the batch number has been requested.
The following is the HPI from her admission to Hospital, admitted on 9/9/2021:  12 yo female who presents to the ED due to painful genital ulcers and inability to urinate because of pain. Parents report patient received a second dose of her COVID vaccine last Friday, 6 days ago. Over the weekend patient had a fever T-max 104 and decreased appetite. Patient also began complaining of vaginal pain and swelling. Her mother states she took a look and noticed an ulcer on her labia.. They were seen by her PCP who obtained an HSV swab and recommended topical benzocaine but there was no improvement of her symptoms. Patient was seen by an OB/GYN  today where the patient had a debridement and was prescribed cephalexin, triamcinolone, and lidocaine. However, later today she began complaining of severe pain with urination due to this ulcer and voluntary urinary retention, which led her to present here.